Peak Bio, Inc. (PKBO)
OTCMKTS · Delayed Price · Currency is USD
0.180
+0.005 (2.86%)
At close: Sep 20, 2024

Peak Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
4484--
Market Cap Growth
-98.72%-94.95%---
Enterprise Value
161392--
Last Close Price
0.180.194.199.74-
PE Ratio
--0.31-5.67-20.16-
PS Ratio
11.5511.54138.30--
PB Ratio
-0.01-0.23-10.38--
P/FCF Ratio
-0.05-0.89-11.02--
P/OCF Ratio
-0.05-0.89-11.23--
EV/Sales Ratio
45.8334.65150.58--
EV/EBITDA Ratio
-1.48-1.36-7.82--
EV/EBIT Ratio
-1.46-1.33-7.72--
EV/FCF Ratio
-2.24-2.68-12.00--
Debt / Equity Ratio
-0.54-0.59-1.05-0.78-0.62
Debt / FCF Ratio
-2.79-2.25-1.11-0.17-0.03
Asset Turnover
0.220.070.140.44-
Quick Ratio
0.010.020.060.070.19
Current Ratio
0.060.120.300.160.35
Return on Assets (ROA)
-262.11%-117.91%-172.05%-471.33%-
Earnings Yield
-113.18%-302.24%-15.57%--
FCF Yield
-1985.41%-112.12%-9.08%--
Buyback Yield / Dilution
-18.70%-19.56%-3.20%--
Total Shareholder Return
-18.70%-19.56%-3.20%--
Source: S&P Capital IQ. Standard template. Financial Sources.